Evaluation of periapical injection of ketorolac for management of endodontic pain

Susan G. Penniston, Kenneth M. Hargreaves

Research output: Contribution to journalArticlepeer-review

41 Scopus citations


Effective pain management of the endodontic emergency patient is often a problem. Ketorolac tromethamine is the first nonsteroidal anti-inflammatory drug available for intramuscular injection in the United States. Although its analgesic efficacy is comparable with opiates after intramuscular injection, to date no study has evaluated its efficacy after intraoral periapical injection. Fifty-two endodontic emergency patients were injected (injection routes = intraoral infiltration/intramuscular deltoid) on a double-blind basis with either: (i) placebo/placebo, (ii) 30 mg ketorolac/placebo, (iii) placebo/30 mg ketorolac, or (iv) 2% mepivicaine with 1:20 K levonordefrin/placebo. Infiltration injection of ketorolac at on oral site produced significant analgesic effects, particularly in treating pain of mandibular origin. These results suggest that intraoral injection of ketorolac may prove to be a useful adjunct in the management of endodontic pain patients. Further studies are required to replicate these findings and to develop optimal treatment combinations.

Original languageEnglish (US)
Pages (from-to)55-59
Number of pages5
JournalJournal of endodontics
Issue number2
StatePublished - 1996
Externally publishedYes

ASJC Scopus subject areas

  • General Dentistry


Dive into the research topics of 'Evaluation of periapical injection of ketorolac for management of endodontic pain'. Together they form a unique fingerprint.

Cite this